Akira Miyake
Concepts (759)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Individuality | 19 | 2023 | 146 | 3.530 |
Why?
| Executive Function | 13 | 2019 | 373 | 2.380 |
Why?
| Memory, Short-Term | 11 | 2021 | 224 | 1.970 |
Why?
| Cognition | 16 | 2023 | 981 | 1.760 |
Why?
| Attention | 14 | 2023 | 394 | 1.570 |
Why?
| Reading | 7 | 2017 | 149 | 1.360 |
Why?
| Aptitude | 6 | 2017 | 38 | 1.220 |
Why?
| Self-Control | 3 | 2023 | 50 | 1.140 |
Why?
| Ego | 3 | 2023 | 11 | 0.940 |
Why?
| Self Concept | 2 | 2016 | 218 | 0.790 |
Why?
| Memory | 6 | 2016 | 212 | 0.720 |
Why?
| Universities | 2 | 2021 | 341 | 0.720 |
Why?
| Reaction Time | 9 | 2018 | 374 | 0.710 |
Why?
| Psychomotor Performance | 6 | 2018 | 278 | 0.710 |
Why?
| Anxiety | 2 | 2016 | 854 | 0.670 |
Why?
| Pessimism | 1 | 2019 | 4 | 0.660 |
Why?
| Internal-External Control | 2 | 2016 | 67 | 0.640 |
Why?
| Task Performance and Analysis | 2 | 2016 | 160 | 0.630 |
Why?
| Comprehension | 2 | 2017 | 158 | 0.610 |
Why?
| Psycholinguistics | 2 | 2017 | 17 | 0.600 |
Why?
| Evoked Potentials | 2 | 2017 | 110 | 0.560 |
Why?
| Students | 3 | 2022 | 503 | 0.550 |
Why?
| Neuropsychological Tests | 14 | 2017 | 920 | 0.520 |
Why?
| Orientation | 3 | 2002 | 39 | 0.510 |
Why?
| Epidermal Growth Factor | 5 | 1998 | 161 | 0.500 |
Why?
| Cerebral Cortex | 3 | 2017 | 386 | 0.480 |
Why?
| Humans | 102 | 2023 | 115741 | 0.460 |
Why?
| Space Perception | 4 | 2016 | 62 | 0.440 |
Why?
| Cooperative Behavior | 1 | 2016 | 390 | 0.440 |
Why?
| Female | 74 | 2022 | 60018 | 0.440 |
Why?
| Learning | 2 | 2022 | 358 | 0.430 |
Why?
| Verbal Behavior | 2 | 2004 | 43 | 0.430 |
Why?
| Interpersonal Relations | 1 | 2016 | 342 | 0.430 |
Why?
| Racism | 1 | 2015 | 102 | 0.430 |
Why?
| Cognition Disorders | 4 | 2023 | 475 | 0.410 |
Why?
| Ether-A-Go-Go Potassium Channels | 2 | 2009 | 4 | 0.390 |
Why?
| Male | 53 | 2021 | 56050 | 0.380 |
Why?
| Mental Recall | 6 | 2008 | 173 | 0.370 |
Why?
| Cues | 4 | 2016 | 298 | 0.370 |
Why?
| Physics | 1 | 2010 | 18 | 0.370 |
Why?
| Language | 3 | 2016 | 258 | 0.370 |
Why?
| Social Values | 1 | 2010 | 36 | 0.360 |
Why?
| Achievement | 1 | 2010 | 54 | 0.360 |
Why?
| Young Adult | 16 | 2019 | 10518 | 0.350 |
Why?
| Frontal Lobe | 3 | 2008 | 139 | 0.340 |
Why?
| Heart Defects, Congenital | 4 | 2022 | 666 | 0.340 |
Why?
| Chromans | 3 | 1994 | 21 | 0.340 |
Why?
| Verbal Learning | 2 | 2002 | 63 | 0.330 |
Why?
| Pattern Recognition, Visual | 3 | 2015 | 86 | 0.330 |
Why?
| Brain | 4 | 2016 | 2373 | 0.330 |
Why?
| Phospholipases A | 3 | 1994 | 101 | 0.320 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2009 | 174 | 0.320 |
Why?
| Receptors, Cholecystokinin | 4 | 1997 | 5 | 0.320 |
Why?
| Adult | 36 | 2023 | 30789 | 0.310 |
Why?
| Models, Psychological | 4 | 2016 | 299 | 0.300 |
Why?
| Goals | 3 | 2015 | 158 | 0.300 |
Why?
| Problem Solving | 3 | 2008 | 141 | 0.300 |
Why?
| Potassium Channels | 4 | 2003 | 121 | 0.290 |
Why?
| Attention Deficit Disorder with Hyperactivity | 3 | 2023 | 362 | 0.290 |
Why?
| Prolactin | 7 | 2000 | 95 | 0.290 |
Why?
| Transforming Growth Factor alpha | 3 | 1996 | 53 | 0.280 |
Why?
| Visual Perception | 4 | 2002 | 141 | 0.280 |
Why?
| ErbB Receptors | 5 | 1996 | 557 | 0.270 |
Why?
| Thinking | 2 | 2021 | 54 | 0.270 |
Why?
| Gene-Environment Interaction | 3 | 2017 | 186 | 0.270 |
Why?
| Adolescent | 26 | 2019 | 17922 | 0.270 |
Why?
| Music | 1 | 2006 | 35 | 0.260 |
Why?
| Decidua | 3 | 1997 | 23 | 0.260 |
Why?
| Receptors, Serotonin | 4 | 2000 | 32 | 0.250 |
Why?
| Fallopian Tubes | 3 | 1999 | 29 | 0.250 |
Why?
| Molecular Sequence Data | 15 | 2008 | 2790 | 0.250 |
Why?
| Hypoplastic Left Heart Syndrome | 2 | 2018 | 114 | 0.250 |
Why?
| Receptors, Interleukin | 2 | 1995 | 39 | 0.250 |
Why?
| Psychological Theory | 2 | 2016 | 96 | 0.250 |
Why?
| Growth Substances | 4 | 1998 | 136 | 0.240 |
Why?
| Pituitary Gland | 5 | 1997 | 152 | 0.240 |
Why?
| Research Design | 4 | 2021 | 946 | 0.240 |
Why?
| RNA, Messenger | 15 | 2000 | 2574 | 0.230 |
Why?
| Gene Expression | 7 | 2000 | 1436 | 0.230 |
Why?
| Twins, Dizygotic | 4 | 2017 | 182 | 0.230 |
Why?
| Twins, Monozygotic | 4 | 2017 | 210 | 0.220 |
Why?
| Electroencephalography | 2 | 2017 | 365 | 0.220 |
Why?
| Adolescent Development | 2 | 2016 | 83 | 0.220 |
Why?
| Phenols | 2 | 1994 | 82 | 0.220 |
Why?
| Potassium Channels, Voltage-Gated | 2 | 2002 | 48 | 0.210 |
Why?
| Long QT Syndrome | 2 | 2014 | 59 | 0.210 |
Why?
| Nerve Tissue Proteins | 3 | 2008 | 535 | 0.210 |
Why?
| Ovarian Neoplasms | 4 | 1999 | 407 | 0.210 |
Why?
| Pseudohypoparathyroidism | 1 | 2001 | 3 | 0.200 |
Why?
| Laryngismus | 1 | 2001 | 6 | 0.200 |
Why?
| Animals | 47 | 2009 | 32104 | 0.190 |
Why?
| Blood Alcohol Content | 1 | 2021 | 5 | 0.190 |
Why?
| Reproducibility of Results | 4 | 2016 | 2824 | 0.190 |
Why?
| Blotting, Northern | 8 | 1998 | 194 | 0.190 |
Why?
| Saccades | 2 | 2015 | 35 | 0.180 |
Why?
| Chemotactic Factors | 2 | 1997 | 47 | 0.180 |
Why?
| Chemokines, CXC | 2 | 1997 | 58 | 0.180 |
Why?
| Surveys and Questionnaires | 5 | 2019 | 4669 | 0.170 |
Why?
| Polymerase Chain Reaction | 8 | 2001 | 1001 | 0.170 |
Why?
| Telencephalon | 1 | 1999 | 15 | 0.170 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 17 | 0.170 |
Why?
| Amino Acid Sequence | 11 | 2008 | 2000 | 0.170 |
Why?
| Cell Line | 10 | 2003 | 2651 | 0.170 |
Why?
| Interleukin-6 | 4 | 1997 | 677 | 0.170 |
Why?
| Mice | 19 | 2009 | 15052 | 0.160 |
Why?
| Rats | 18 | 2000 | 5033 | 0.160 |
Why?
| Emotions | 1 | 2023 | 477 | 0.160 |
Why?
| Scimitar Syndrome | 1 | 2018 | 6 | 0.160 |
Why?
| Heterotaxy Syndrome | 1 | 2018 | 10 | 0.160 |
Why?
| Hypothalamus | 2 | 1996 | 150 | 0.150 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 1997 | 350 | 0.150 |
Why?
| Cardiovascular Surgical Procedures | 1 | 2018 | 30 | 0.150 |
Why?
| Twins | 4 | 2014 | 240 | 0.150 |
Why?
| Guidelines as Topic | 1 | 2000 | 248 | 0.150 |
Why?
| Child Development | 2 | 2012 | 390 | 0.150 |
Why?
| Pyridazines | 1 | 1997 | 46 | 0.140 |
Why?
| Menstrual Cycle | 2 | 1995 | 109 | 0.140 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1999 | 171 | 0.140 |
Why?
| Follicle Stimulating Hormone | 8 | 1997 | 214 | 0.140 |
Why?
| Estradiol | 4 | 1996 | 452 | 0.140 |
Why?
| Cystadenocarcinoma | 1 | 1996 | 2 | 0.140 |
Why?
| CA-125 Antigen | 1 | 1996 | 13 | 0.140 |
Why?
| Fibroblast Growth Factors | 1 | 1998 | 162 | 0.140 |
Why?
| Arteriovenous Malformations | 1 | 1996 | 24 | 0.140 |
Why?
| Tetradecanoylphorbol Acetate | 2 | 1993 | 153 | 0.140 |
Why?
| Monosaccharide Transport Proteins | 1 | 1996 | 45 | 0.140 |
Why?
| Educational Measurement | 2 | 2010 | 262 | 0.130 |
Why?
| Motion Pictures | 1 | 2016 | 13 | 0.130 |
Why?
| Alcoholic Intoxication | 1 | 2016 | 63 | 0.130 |
Why?
| Mice, Inbred ICR | 5 | 1997 | 111 | 0.130 |
Why?
| Random Allocation | 3 | 2018 | 337 | 0.130 |
Why?
| Genetic Phenomena | 1 | 2015 | 8 | 0.130 |
Why?
| Cloning, Molecular | 6 | 2003 | 523 | 0.130 |
Why?
| Sample Size | 1 | 2016 | 115 | 0.130 |
Why?
| Base Sequence | 6 | 2001 | 2114 | 0.130 |
Why?
| Adipose Tissue | 2 | 1997 | 555 | 0.130 |
Why?
| Japan | 5 | 2019 | 88 | 0.130 |
Why?
| Association | 1 | 2015 | 11 | 0.120 |
Why?
| Substance-Related Disorders | 2 | 2017 | 951 | 0.120 |
Why?
| Dangerous Behavior | 1 | 2015 | 20 | 0.120 |
Why?
| Vagina | 1 | 1996 | 148 | 0.120 |
Why?
| Genotype | 2 | 2011 | 1787 | 0.120 |
Why?
| Depression | 2 | 2015 | 1147 | 0.120 |
Why?
| Alternative Splicing | 2 | 2000 | 187 | 0.120 |
Why?
| Intelligence | 4 | 2011 | 132 | 0.120 |
Why?
| Arousal | 1 | 2015 | 153 | 0.120 |
Why?
| 3T3 Cells | 1 | 1994 | 137 | 0.120 |
Why?
| Dextrocardia | 1 | 2014 | 3 | 0.120 |
Why?
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 10 | 0.120 |
Why?
| Pregnancy, Animal | 1 | 1994 | 52 | 0.120 |
Why?
| Phonetics | 2 | 2006 | 46 | 0.120 |
Why?
| Stents | 1 | 2018 | 477 | 0.120 |
Why?
| Transplantation, Heterologous | 1 | 1994 | 187 | 0.120 |
Why?
| Neoplasm Transplantation | 1 | 1994 | 235 | 0.120 |
Why?
| Exons | 1 | 1995 | 300 | 0.120 |
Why?
| Genitalia, Female | 1 | 2014 | 37 | 0.120 |
Why?
| Electrocardiography | 2 | 2014 | 564 | 0.120 |
Why?
| Saliva | 1 | 1995 | 189 | 0.120 |
Why?
| Peptides | 2 | 1996 | 864 | 0.110 |
Why?
| Ethanol | 1 | 2018 | 549 | 0.110 |
Why?
| Tumor Cells, Cultured | 9 | 2000 | 850 | 0.110 |
Why?
| Carrageenan | 1 | 1993 | 6 | 0.110 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 1993 | 301 | 0.110 |
Why?
| Macrophages, Peritoneal | 1 | 1994 | 93 | 0.110 |
Why?
| Anti-Asthmatic Agents | 1 | 1997 | 350 | 0.110 |
Why?
| Recombinant Proteins | 5 | 1999 | 1243 | 0.110 |
Why?
| Motivation | 2 | 2014 | 498 | 0.110 |
Why?
| Dinoprostone | 1 | 1994 | 186 | 0.110 |
Why?
| Uterus | 4 | 1999 | 193 | 0.110 |
Why?
| Pituitary Gland, Anterior | 5 | 1996 | 41 | 0.110 |
Why?
| Impulsive Behavior | 1 | 2014 | 109 | 0.110 |
Why?
| Wolff-Parkinson-White Syndrome | 1 | 2013 | 16 | 0.110 |
Why?
| Adipocytes | 1 | 1994 | 188 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 8 | 2000 | 1870 | 0.110 |
Why?
| Magnetic Resonance Imaging | 4 | 2008 | 3122 | 0.110 |
Why?
| Data Collection | 1 | 2016 | 636 | 0.110 |
Why?
| Ventricular Fibrillation | 1 | 2013 | 51 | 0.110 |
Why?
| Sequence Homology, Amino Acid | 6 | 2002 | 352 | 0.110 |
Why?
| Sincalide | 4 | 1997 | 5 | 0.100 |
Why?
| Phenotype | 4 | 2017 | 2839 | 0.100 |
Why?
| Calcium | 6 | 2000 | 1103 | 0.100 |
Why?
| Electrodes, Implanted | 1 | 2013 | 92 | 0.100 |
Why?
| Alcohol Drinking | 1 | 2018 | 650 | 0.100 |
Why?
| Immunohistochemistry | 5 | 1997 | 1642 | 0.100 |
Why?
| Equol | 1 | 2012 | 2 | 0.100 |
Why?
| Biomarkers, Tumor | 2 | 1996 | 1048 | 0.100 |
Why?
| Tissue Distribution | 5 | 2003 | 324 | 0.100 |
Why?
| Phytoestrogens | 1 | 2012 | 15 | 0.100 |
Why?
| Rats, Wistar | 8 | 1997 | 368 | 0.100 |
Why?
| Skin Aging | 1 | 2012 | 19 | 0.100 |
Why?
| Cells, Cultured | 10 | 2001 | 3914 | 0.100 |
Why?
| In Situ Hybridization | 5 | 2001 | 298 | 0.100 |
Why?
| Longitudinal Studies | 6 | 2017 | 2420 | 0.100 |
Why?
| Transfection | 4 | 2003 | 866 | 0.100 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 1997 | 1137 | 0.100 |
Why?
| Hernias, Diaphragmatic, Congenital | 1 | 2014 | 187 | 0.100 |
Why?
| Placenta | 2 | 1997 | 624 | 0.100 |
Why?
| Binding, Competitive | 4 | 2000 | 200 | 0.100 |
Why?
| DNA, Complementary | 5 | 2001 | 258 | 0.100 |
Why?
| Glucose | 1 | 1996 | 904 | 0.100 |
Why?
| Factor Analysis, Statistical | 3 | 2011 | 261 | 0.090 |
Why?
| Pregnancy | 11 | 2022 | 5553 | 0.090 |
Why?
| Hyponatremia | 1 | 2011 | 37 | 0.090 |
Why?
| Reversal Learning | 1 | 2010 | 10 | 0.090 |
Why?
| Stereotyping | 1 | 2010 | 39 | 0.090 |
Why?
| Sodium | 1 | 2011 | 183 | 0.090 |
Why?
| Temperament | 1 | 2010 | 47 | 0.090 |
Why?
| Pituitary Function Tests | 1 | 1989 | 3 | 0.090 |
Why?
| Beclin-1 | 1 | 2009 | 9 | 0.090 |
Why?
| Bayes Theorem | 2 | 2022 | 334 | 0.090 |
Why?
| Autonomic Nervous System | 1 | 2010 | 70 | 0.090 |
Why?
| Postmenopause | 1 | 2012 | 300 | 0.090 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2010 | 71 | 0.090 |
Why?
| In Vitro Techniques | 3 | 1997 | 1044 | 0.090 |
Why?
| Ion Channel Gating | 3 | 2002 | 83 | 0.090 |
Why?
| Social Environment | 2 | 2009 | 286 | 0.090 |
Why?
| Maze Learning | 1 | 2009 | 87 | 0.090 |
Why?
| Defibrillators, Implantable | 1 | 2013 | 285 | 0.080 |
Why?
| Mice, Inbred DBA | 1 | 2009 | 173 | 0.080 |
Why?
| Phospholipases A2 | 3 | 1994 | 76 | 0.080 |
Why?
| Models, Neurological | 1 | 2011 | 213 | 0.080 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 1994 | 1147 | 0.080 |
Why?
| Drug Design | 1 | 2010 | 156 | 0.080 |
Why?
| Epilepsy | 1 | 2013 | 291 | 0.080 |
Why?
| Gene Expression Regulation | 2 | 1995 | 2353 | 0.080 |
Why?
| Atrial Fibrillation | 1 | 2013 | 325 | 0.080 |
Why?
| Motor Skills | 1 | 2009 | 80 | 0.080 |
Why?
| Heart Failure | 1 | 2022 | 1964 | 0.080 |
Why?
| Fontan Procedure | 1 | 2011 | 160 | 0.080 |
Why?
| Time Factors | 9 | 2011 | 6171 | 0.080 |
Why?
| Psoriasis | 1 | 2009 | 75 | 0.080 |
Why?
| Gonadotropin-Releasing Hormone | 6 | 1997 | 193 | 0.080 |
Why?
| Enzyme Inhibitors | 2 | 2010 | 757 | 0.080 |
Why?
| Blastocyst | 2 | 2001 | 43 | 0.080 |
Why?
| Speech Perception | 2 | 2002 | 80 | 0.080 |
Why?
| Amyloid beta-Peptides | 1 | 2010 | 191 | 0.080 |
Why?
| Infant, Newborn | 4 | 2022 | 5061 | 0.080 |
Why?
| Psychological Tests | 1 | 2008 | 123 | 0.070 |
Why?
| Age Factors | 5 | 2016 | 2911 | 0.070 |
Why?
| Diagnosis, Differential | 4 | 2013 | 1357 | 0.070 |
Why?
| Growth Inhibitors | 2 | 1997 | 45 | 0.070 |
Why?
| Patch-Clamp Techniques | 4 | 2003 | 245 | 0.070 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2009 | 243 | 0.070 |
Why?
| Analysis of Variance | 2 | 2004 | 1230 | 0.070 |
Why?
| Natriuretic Peptide, Brain | 2 | 2022 | 99 | 0.070 |
Why?
| Computer Simulation | 1 | 2011 | 884 | 0.070 |
Why?
| Trans-Activators | 3 | 2000 | 370 | 0.070 |
Why?
| Conduct Disorder | 1 | 2009 | 193 | 0.070 |
Why?
| RNA, Neoplasm | 2 | 1998 | 80 | 0.070 |
Why?
| Orbital Neoplasms | 1 | 2006 | 21 | 0.070 |
Why?
| Kinetics | 7 | 1997 | 1569 | 0.070 |
Why?
| Paraventricular Hypothalamic Nucleus | 2 | 1997 | 36 | 0.070 |
Why?
| Chromosome Mapping | 2 | 1999 | 489 | 0.070 |
Why?
| Middle Aged | 12 | 2019 | 27069 | 0.070 |
Why?
| Child | 13 | 2019 | 18503 | 0.070 |
Why?
| Endometrial Neoplasms | 2 | 1998 | 151 | 0.070 |
Why?
| Social Behavior | 1 | 2009 | 269 | 0.070 |
Why?
| Mice, Knockout | 2 | 2009 | 2604 | 0.070 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2008 | 192 | 0.070 |
Why?
| Pituitary Neoplasms | 3 | 2000 | 157 | 0.070 |
Why?
| Luteinizing Hormone | 6 | 1997 | 169 | 0.070 |
Why?
| Arachidonic Acid | 3 | 2003 | 117 | 0.070 |
Why?
| Carcinoma, Transitional Cell | 1 | 2006 | 54 | 0.070 |
Why?
| Benzodiazepines | 2 | 1997 | 115 | 0.070 |
Why?
| Epithelium | 3 | 1996 | 297 | 0.060 |
Why?
| Protein-Tyrosine Kinases | 3 | 1997 | 396 | 0.060 |
Why?
| Aging | 1 | 1995 | 1632 | 0.060 |
Why?
| Blotting, Southern | 2 | 1995 | 66 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1739 | 0.060 |
Why?
| Alzheimer Disease | 1 | 2010 | 438 | 0.060 |
Why?
| Proto-Oncogene Proteins | 2 | 2000 | 609 | 0.060 |
Why?
| Genetic Predisposition to Disease | 2 | 2017 | 2129 | 0.060 |
Why?
| Receptors, Interleukin-6 | 2 | 1995 | 34 | 0.060 |
Why?
| Postoperative Complications | 2 | 2018 | 2164 | 0.060 |
Why?
| Severity of Illness Index | 2 | 2009 | 2586 | 0.060 |
Why?
| Mice, Transgenic | 1 | 2009 | 1970 | 0.060 |
Why?
| DNA Primers | 2 | 1995 | 514 | 0.060 |
Why?
| Fixation, Ocular | 1 | 2004 | 18 | 0.060 |
Why?
| Glycoproteins | 2 | 1996 | 309 | 0.060 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 930 | 0.060 |
Why?
| Iodine Radioisotopes | 2 | 1994 | 126 | 0.060 |
Why?
| Radioimmunoassay | 4 | 1994 | 163 | 0.060 |
Why?
| Norepinephrine | 2 | 2011 | 207 | 0.060 |
Why?
| Quinidine | 2 | 2003 | 6 | 0.060 |
Why?
| Urinary Bladder Neoplasms | 1 | 2006 | 197 | 0.060 |
Why?
| Schizophrenia | 1 | 2008 | 418 | 0.060 |
Why?
| Visual Fields | 2 | 2002 | 77 | 0.050 |
Why?
| Gene Expression Regulation, Developmental | 2 | 1998 | 794 | 0.050 |
Why?
| Inflammation | 1 | 1993 | 2500 | 0.050 |
Why?
| Concept Formation | 1 | 2002 | 26 | 0.050 |
Why?
| Treatment Outcome | 4 | 2018 | 9162 | 0.050 |
Why?
| Vocabulary | 1 | 2002 | 40 | 0.050 |
Why?
| Serotonin Receptor Agonists | 2 | 2000 | 27 | 0.050 |
Why?
| Pituitary Hormone-Releasing Hormones | 2 | 1994 | 10 | 0.050 |
Why?
| Discrimination Learning | 2 | 2008 | 47 | 0.050 |
Why?
| Biguanides | 2 | 2000 | 12 | 0.050 |
Why?
| Adolescent Behavior | 1 | 2007 | 480 | 0.050 |
Why?
| Blotting, Western | 2 | 1995 | 1153 | 0.050 |
Why?
| Dopamine | 2 | 1996 | 237 | 0.050 |
Why?
| Edema | 2 | 1993 | 119 | 0.050 |
Why?
| Transcription, Genetic | 4 | 1997 | 1310 | 0.050 |
Why?
| Rabbits | 3 | 1993 | 752 | 0.050 |
Why?
| Natriuretic Peptides | 1 | 2022 | 8 | 0.050 |
Why?
| Mathematics | 1 | 2002 | 100 | 0.050 |
Why?
| Xenopus | 3 | 2001 | 99 | 0.050 |
Why?
| Prevalence | 3 | 2019 | 2269 | 0.050 |
Why?
| Calcium Compounds | 1 | 2001 | 4 | 0.050 |
Why?
| Atrial Natriuretic Factor | 1 | 2022 | 58 | 0.050 |
Why?
| Signal Transduction | 5 | 2001 | 4541 | 0.050 |
Why?
| Spatial Behavior | 1 | 2001 | 21 | 0.050 |
Why?
| Neurons | 4 | 1997 | 1298 | 0.050 |
Why?
| Lactates | 1 | 2001 | 83 | 0.050 |
Why?
| Microsurgery | 1 | 2022 | 61 | 0.050 |
Why?
| Hypocalcemia | 1 | 2001 | 31 | 0.050 |
Why?
| Sequence Alignment | 2 | 1999 | 327 | 0.050 |
Why?
| Tritium | 2 | 2000 | 69 | 0.050 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 1999 | 114 | 0.050 |
Why?
| Predictive Value of Tests | 3 | 2011 | 1825 | 0.050 |
Why?
| Cell Membrane | 2 | 1994 | 683 | 0.050 |
Why?
| Acute-Phase Proteins | 2 | 1997 | 64 | 0.040 |
Why?
| Mesoderm | 1 | 2001 | 138 | 0.040 |
Why?
| DNA-Binding Proteins | 2 | 1997 | 1316 | 0.040 |
Why?
| Mice, Inbred C57BL | 1 | 2009 | 4773 | 0.040 |
Why?
| Imagination | 1 | 2000 | 15 | 0.040 |
Why?
| Radioligand Assay | 2 | 2000 | 45 | 0.040 |
Why?
| Infant | 5 | 2018 | 7979 | 0.040 |
Why?
| DNA | 3 | 1995 | 1356 | 0.040 |
Why?
| Evolution, Molecular | 2 | 2008 | 440 | 0.040 |
Why?
| Hormone Antagonists | 2 | 1997 | 38 | 0.040 |
Why?
| Electrophysiology | 4 | 2003 | 202 | 0.040 |
Why?
| Vasodilator Agents | 1 | 2022 | 308 | 0.040 |
Why?
| Receptors, Eph Family | 1 | 1999 | 4 | 0.040 |
Why?
| Tetraethylammonium | 1 | 1999 | 15 | 0.040 |
Why?
| Phylogeny | 2 | 2003 | 805 | 0.040 |
Why?
| Chromosomes, Human, Pair 12 | 1 | 1999 | 21 | 0.040 |
Why?
| Receptor, EphB4 | 1 | 1999 | 23 | 0.040 |
Why?
| Arrhythmias, Cardiac | 1 | 2022 | 279 | 0.040 |
Why?
| 3,4-Dihydroxyphenylacetic Acid | 2 | 1996 | 17 | 0.040 |
Why?
| Ovariectomy | 2 | 1996 | 117 | 0.040 |
Why?
| Retrospective Studies | 4 | 2019 | 12633 | 0.040 |
Why?
| Immunoblotting | 2 | 1997 | 281 | 0.040 |
Why?
| GTP-Binding Proteins | 2 | 1999 | 142 | 0.040 |
Why?
| Postpartum Period | 2 | 1999 | 281 | 0.040 |
Why?
| Cytoskeleton | 1 | 2000 | 177 | 0.040 |
Why?
| Cystadenocarcinoma, Papillary | 1 | 1999 | 5 | 0.040 |
Why?
| Fallopian Tube Neoplasms | 1 | 1999 | 15 | 0.040 |
Why?
| Uterine Contraction | 1 | 1999 | 17 | 0.040 |
Why?
| Enoyl-CoA Hydratase | 1 | 1998 | 9 | 0.040 |
Why?
| Adenoma | 1 | 2000 | 187 | 0.040 |
Why?
| Glycoprotein Hormones, alpha Subunit | 1 | 1998 | 22 | 0.040 |
Why?
| Serotonin | 1 | 2000 | 296 | 0.040 |
Why?
| Fibroblast Growth Factor 9 | 1 | 1998 | 2 | 0.040 |
Why?
| Binding Sites | 3 | 1999 | 1177 | 0.040 |
Why?
| Actins | 1 | 2000 | 383 | 0.040 |
Why?
| Research | 1 | 2001 | 396 | 0.040 |
Why?
| Spodoptera | 1 | 1998 | 37 | 0.040 |
Why?
| Progestins | 1 | 1998 | 75 | 0.040 |
Why?
| Baculoviridae | 1 | 1998 | 45 | 0.040 |
Why?
| Photic Stimulation | 2 | 2018 | 203 | 0.040 |
Why?
| Antibody Specificity | 2 | 1997 | 176 | 0.040 |
Why?
| Carcinoma, Embryonal | 1 | 1997 | 2 | 0.040 |
Why?
| Species Specificity | 2 | 1996 | 552 | 0.040 |
Why?
| Drainage | 1 | 2018 | 151 | 0.040 |
Why?
| Medroxyprogesterone Acetate | 2 | 1998 | 29 | 0.040 |
Why?
| Peptones | 1 | 1997 | 1 | 0.040 |
Why?
| Guinea Pigs | 1 | 1997 | 151 | 0.040 |
Why?
| Receptor Protein-Tyrosine Kinases | 1 | 1999 | 225 | 0.040 |
Why?
| Gastric Acid | 1 | 1997 | 13 | 0.040 |
Why?
| Adipose Tissue, Brown | 1 | 1998 | 68 | 0.040 |
Why?
| Leiomyoma | 1 | 1997 | 45 | 0.040 |
Why?
| Endothelin-1 | 1 | 1999 | 167 | 0.040 |
Why?
| Lymphokines | 1 | 1997 | 115 | 0.040 |
Why?
| Pulmonary Veins | 1 | 2018 | 85 | 0.040 |
Why?
| Placental Lactogen | 1 | 1997 | 20 | 0.040 |
Why?
| Neurosecretory Systems | 1 | 1997 | 32 | 0.040 |
Why?
| Vaginal Neoplasms | 1 | 1996 | 11 | 0.040 |
Why?
| Arcuate Nucleus of Hypothalamus | 1 | 1996 | 13 | 0.030 |
Why?
| Uterine Neoplasms | 1 | 1997 | 73 | 0.030 |
Why?
| Tissue Polypeptide Antigen | 1 | 1996 | 2 | 0.030 |
Why?
| Oligopeptides | 2 | 1999 | 248 | 0.030 |
Why?
| Culture Media, Conditioned | 1 | 1997 | 105 | 0.030 |
Why?
| Depression, Chemical | 1 | 1996 | 23 | 0.030 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 1996 | 52 | 0.030 |
Why?
| Phenylurea Compounds | 1 | 1997 | 83 | 0.030 |
Why?
| Oxytocin | 1 | 1996 | 45 | 0.030 |
Why?
| Neoplasm Staging | 2 | 1998 | 1178 | 0.030 |
Why?
| Deoxyglucose | 1 | 1996 | 43 | 0.030 |
Why?
| Trophoblasts | 1 | 1998 | 162 | 0.030 |
Why?
| Structure-Activity Relationship | 1 | 1997 | 511 | 0.030 |
Why?
| Glucose Transporter Type 1 | 1 | 1996 | 42 | 0.030 |
Why?
| Carcinoma | 1 | 1998 | 200 | 0.030 |
Why?
| Cytoplasm | 1 | 1997 | 255 | 0.030 |
Why?
| Potassium Channels, Inwardly Rectifying | 1 | 1996 | 22 | 0.030 |
Why?
| Transcriptional Activation | 1 | 1998 | 340 | 0.030 |
Why?
| Molecular Structure | 1 | 1997 | 447 | 0.030 |
Why?
| Recurrence | 1 | 2019 | 953 | 0.030 |
Why?
| Coenzyme A Ligases | 1 | 1995 | 11 | 0.030 |
Why?
| Submandibular Gland | 1 | 1995 | 15 | 0.030 |
Why?
| Immune Sera | 1 | 1995 | 80 | 0.030 |
Why?
| Piperazines | 2 | 2000 | 314 | 0.030 |
Why?
| Protein Biosynthesis | 1 | 1997 | 390 | 0.030 |
Why?
| Meta-Analysis as Topic | 1 | 2016 | 161 | 0.030 |
Why?
| Molecular Chaperones | 1 | 1996 | 157 | 0.030 |
Why?
| Neoplasm Proteins | 1 | 1998 | 385 | 0.030 |
Why?
| Genetic Heterogeneity | 1 | 1995 | 51 | 0.030 |
Why?
| Azepines | 2 | 2010 | 74 | 0.030 |
Why?
| Receptors, Serotonin, 5-HT3 | 3 | 2000 | 15 | 0.030 |
Why?
| Biological Transport | 1 | 1996 | 375 | 0.030 |
Why?
| Restriction Mapping | 1 | 1995 | 77 | 0.030 |
Why?
| Lipoprotein Lipase | 1 | 1995 | 55 | 0.030 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1997 | 483 | 0.030 |
Why?
| Gastric Mucosa | 1 | 1995 | 46 | 0.030 |
Why?
| Brain Chemistry | 1 | 1995 | 116 | 0.030 |
Why?
| Mice, Inbred C3H | 1 | 1995 | 244 | 0.030 |
Why?
| Thyrotropin-Releasing Hormone | 3 | 1997 | 12 | 0.030 |
Why?
| Muscle Contraction | 2 | 1996 | 397 | 0.030 |
Why?
| Cystadenocarcinoma, Mucinous | 1 | 1994 | 14 | 0.030 |
Why?
| Infertility, Male | 2 | 1985 | 60 | 0.030 |
Why?
| Statistics as Topic | 1 | 2016 | 299 | 0.030 |
Why?
| Gestational Age | 1 | 1997 | 758 | 0.030 |
Why?
| Embolization, Therapeutic | 1 | 1996 | 179 | 0.030 |
Why?
| Vibration | 2 | 1988 | 61 | 0.030 |
Why?
| Salivary Glands | 1 | 1994 | 31 | 0.030 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 795 | 0.030 |
Why?
| Inhibins | 1 | 1994 | 45 | 0.030 |
Why?
| Receptor, Cholecystokinin B | 1 | 1994 | 1 | 0.030 |
Why?
| Gastrins | 1 | 1994 | 8 | 0.030 |
Why?
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 1994 | 14 | 0.030 |
Why?
| Cystadenocarcinoma, Serous | 1 | 1994 | 44 | 0.030 |
Why?
| Haplorhini | 1 | 1994 | 60 | 0.030 |
Why?
| Child, Preschool | 6 | 2011 | 9138 | 0.030 |
Why?
| Eye Infections, Viral | 1 | 1994 | 7 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 1996 | 446 | 0.030 |
Why?
| HTLV-I Infections | 1 | 1994 | 21 | 0.030 |
Why?
| Survival Rate | 1 | 2018 | 1651 | 0.030 |
Why?
| RNA-Directed DNA Polymerase | 1 | 1994 | 34 | 0.030 |
Why?
| Posture | 2 | 1988 | 150 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 1996 | 372 | 0.030 |
Why?
| Receptors, Fibroblast Growth Factor | 1 | 1994 | 63 | 0.030 |
Why?
| Pleurisy | 1 | 1993 | 6 | 0.030 |
Why?
| Vestibular Nuclei | 1 | 1973 | 7 | 0.030 |
Why?
| Hydrolysis | 1 | 1994 | 179 | 0.030 |
Why?
| Ear, External | 1 | 1993 | 23 | 0.030 |
Why?
| Lipoxygenase Inhibitors | 1 | 1993 | 36 | 0.030 |
Why?
| Lipopolysaccharides | 1 | 1997 | 826 | 0.030 |
Why?
| Neuropeptides | 1 | 1993 | 65 | 0.030 |
Why?
| Reference Values | 2 | 1997 | 750 | 0.030 |
Why?
| Cyclooxygenase Inhibitors | 1 | 1993 | 72 | 0.030 |
Why?
| Neurotransmitter Uptake Inhibitors | 1 | 1993 | 4 | 0.030 |
Why?
| Cardiac Conduction System Disease | 1 | 2013 | 4 | 0.030 |
Why?
| Gestrinone | 1 | 1992 | 1 | 0.030 |
Why?
| Mothers | 1 | 2019 | 666 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 1994 | 214 | 0.030 |
Why?
| Heart Ventricles | 1 | 2018 | 722 | 0.030 |
Why?
| Mice, Nude | 1 | 1994 | 639 | 0.030 |
Why?
| Extracellular Space | 1 | 1993 | 122 | 0.030 |
Why?
| Receptors, Cell Surface | 2 | 1985 | 356 | 0.030 |
Why?
| Cerebral Ventricles | 1 | 1993 | 47 | 0.030 |
Why?
| Down-Regulation | 1 | 1995 | 601 | 0.030 |
Why?
| Cyclic AMP | 1 | 1993 | 227 | 0.030 |
Why?
| Energy Intake | 1 | 1995 | 414 | 0.030 |
Why?
| Uveitis | 1 | 1994 | 115 | 0.030 |
Why?
| Myocardium | 1 | 1998 | 926 | 0.030 |
Why?
| Therapy, Computer-Assisted | 1 | 2013 | 58 | 0.030 |
Why?
| Androgen-Insensitivity Syndrome | 2 | 1985 | 6 | 0.030 |
Why?
| Triglycerides | 1 | 1994 | 473 | 0.030 |
Why?
| Phospholipids | 1 | 1994 | 202 | 0.030 |
Why?
| Mutation, Missense | 1 | 2014 | 296 | 0.030 |
Why?
| Weight Gain | 1 | 1995 | 453 | 0.030 |
Why?
| Isoflavones | 1 | 2012 | 16 | 0.030 |
Why?
| Death, Sudden, Cardiac | 1 | 2013 | 160 | 0.020 |
Why?
| Cell Division | 1 | 1993 | 759 | 0.020 |
Why?
| Dihydrotestosterone | 2 | 1996 | 39 | 0.020 |
Why?
| Social Control, Informal | 1 | 2011 | 18 | 0.020 |
Why?
| Proteins | 1 | 1997 | 920 | 0.020 |
Why?
| Lipid Metabolism | 1 | 1994 | 449 | 0.020 |
Why?
| Placebos | 1 | 2012 | 197 | 0.020 |
Why?
| Genetics, Behavioral | 1 | 2011 | 43 | 0.020 |
Why?
| Central Venous Pressure | 1 | 2011 | 12 | 0.020 |
Why?
| Cell Differentiation | 2 | 1997 | 1700 | 0.020 |
Why?
| Renin | 1 | 2011 | 31 | 0.020 |
Why?
| Ovary | 1 | 1992 | 190 | 0.020 |
Why?
| Models, Genetic | 1 | 2014 | 570 | 0.020 |
Why?
| Pain | 1 | 1997 | 712 | 0.020 |
Why?
| Arginine Vasopressin | 1 | 2011 | 46 | 0.020 |
Why?
| Equipment Design | 1 | 2013 | 517 | 0.020 |
Why?
| Peptides, Cyclic | 1 | 1993 | 262 | 0.020 |
Why?
| Sheep | 1 | 1993 | 765 | 0.020 |
Why?
| Risk Factors | 2 | 2017 | 8702 | 0.020 |
Why?
| Testis | 3 | 1985 | 134 | 0.020 |
Why?
| Flurbiprofen | 1 | 2010 | 3 | 0.020 |
Why?
| Stroop Test | 1 | 2010 | 26 | 0.020 |
Why?
| Aspartic Acid Endopeptidases | 1 | 2010 | 21 | 0.020 |
Why?
| Hyperprolactinemia | 1 | 1990 | 4 | 0.020 |
Why?
| Prolactinoma | 1 | 1990 | 11 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2011 | 501 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2014 | 1441 | 0.020 |
Why?
| Amyloid beta-Protein Precursor | 1 | 2010 | 54 | 0.020 |
Why?
| Adenocarcinoma | 1 | 1996 | 799 | 0.020 |
Why?
| Dermatologic Agents | 2 | 2009 | 57 | 0.020 |
Why?
| Membrane Potentials | 3 | 2000 | 251 | 0.020 |
Why?
| Alanine | 1 | 2010 | 103 | 0.020 |
Why?
| Taurine | 1 | 2010 | 41 | 0.020 |
Why?
| Sensitivity and Specificity | 2 | 2009 | 1730 | 0.020 |
Why?
| Ovarian Diseases | 1 | 1989 | 12 | 0.020 |
Why?
| Hypothalamic Diseases | 1 | 1989 | 17 | 0.020 |
Why?
| Pituitary Diseases | 1 | 1989 | 22 | 0.020 |
Why?
| Follow-Up Studies | 2 | 2010 | 4442 | 0.020 |
Why?
| Environment | 1 | 2011 | 337 | 0.020 |
Why?
| Neural Pathways | 1 | 2011 | 260 | 0.020 |
Why?
| Infertility, Female | 1 | 1990 | 94 | 0.020 |
Why?
| Electric Conductivity | 2 | 2002 | 91 | 0.020 |
Why?
| Protein Binding | 1 | 1994 | 1917 | 0.020 |
Why?
| Color | 1 | 2009 | 75 | 0.020 |
Why?
| Calibration | 1 | 2009 | 129 | 0.020 |
Why?
| Photography | 1 | 2009 | 89 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2011 | 816 | 0.020 |
Why?
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2009 | 57 | 0.020 |
Why?
| Cyclosporine | 1 | 2009 | 169 | 0.020 |
Why?
| Kidney | 1 | 1995 | 1207 | 0.020 |
Why?
| Regression Analysis | 1 | 2011 | 959 | 0.020 |
Why?
| Oxygen Consumption | 1 | 2011 | 573 | 0.020 |
Why?
| Dietary Supplements | 1 | 2012 | 458 | 0.020 |
Why?
| Proportional Hazards Models | 1 | 2011 | 1088 | 0.020 |
Why?
| Antigens, Neoplasm | 1 | 1989 | 223 | 0.020 |
Why?
| Intelligence Tests | 1 | 2007 | 59 | 0.020 |
Why?
| Schizophrenic Psychology | 1 | 2008 | 86 | 0.020 |
Why?
| Apoptosis | 1 | 1996 | 2377 | 0.020 |
Why?
| Estrogens, Conjugated (USP) | 2 | 1978 | 34 | 0.020 |
Why?
| Double-Blind Method | 1 | 2012 | 1660 | 0.020 |
Why?
| Neurons, Afferent | 1 | 1988 | 88 | 0.020 |
Why?
| Janus Kinase 1 | 2 | 1997 | 23 | 0.020 |
Why?
| Pilot Projects | 1 | 2012 | 1384 | 0.020 |
Why?
| Organ Size | 1 | 2008 | 434 | 0.020 |
Why?
| Foot | 1 | 1988 | 104 | 0.020 |
Why?
| Bromocriptine | 2 | 1990 | 27 | 0.020 |
Why?
| Protein Kinase C | 2 | 1999 | 274 | 0.020 |
Why?
| Faculty | 1 | 2007 | 131 | 0.020 |
Why?
| Cystectomy | 1 | 2006 | 32 | 0.020 |
Why?
| Enzyme Activation | 2 | 1999 | 793 | 0.020 |
Why?
| Preoperative Care | 2 | 1999 | 319 | 0.020 |
Why?
| Menotropins | 1 | 1985 | 2 | 0.020 |
Why?
| Ophthalmologic Surgical Procedures | 1 | 2006 | 58 | 0.020 |
Why?
| Progesterone | 3 | 1996 | 232 | 0.020 |
Why?
| Thalamic Nuclei | 2 | 1984 | 8 | 0.020 |
Why?
| Fatal Outcome | 1 | 2006 | 286 | 0.020 |
Why?
| Alleles | 1 | 2008 | 794 | 0.020 |
Why?
| Molecular Weight | 2 | 1996 | 329 | 0.020 |
Why?
| Models, Biological | 2 | 2003 | 1646 | 0.020 |
Why?
| Behavior, Animal | 1 | 2008 | 472 | 0.020 |
Why?
| Cats | 4 | 1984 | 204 | 0.010 |
Why?
| Comorbidity | 1 | 2009 | 1473 | 0.010 |
Why?
| Aged | 4 | 2006 | 19294 | 0.010 |
Why?
| Phosphorylation | 2 | 1999 | 1571 | 0.010 |
Why?
| Propafenone | 1 | 2003 | 2 | 0.010 |
Why?
| Quinine | 1 | 2003 | 11 | 0.010 |
Why?
| Barium | 1 | 2003 | 25 | 0.010 |
Why?
| Ethanolamines | 1 | 2003 | 20 | 0.010 |
Why?
| Glyburide | 1 | 2003 | 35 | 0.010 |
Why?
| Lidocaine | 1 | 2003 | 42 | 0.010 |
Why?
| Docosahexaenoic Acids | 1 | 2003 | 69 | 0.010 |
Why?
| Biopsy | 1 | 2006 | 1056 | 0.010 |
Why?
| Anti-Arrhythmia Agents | 1 | 2003 | 106 | 0.010 |
Why?
| Protein Kinase Inhibitors | 2 | 1999 | 790 | 0.010 |
Why?
| Prognosis | 1 | 2010 | 3343 | 0.010 |
Why?
| Fatty Acids, Nonesterified | 1 | 2003 | 151 | 0.010 |
Why?
| Delayed Rectifier Potassium Channels | 1 | 2002 | 9 | 0.010 |
Why?
| Shab Potassium Channels | 1 | 2002 | 18 | 0.010 |
Why?
| Risk Assessment | 1 | 2011 | 2990 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 2003 | 515 | 0.010 |
Why?
| Analgesics, Non-Narcotic | 1 | 2003 | 117 | 0.010 |
Why?
| Lung | 1 | 2014 | 3673 | 0.010 |
Why?
| Fetal Proteins | 1 | 2001 | 16 | 0.010 |
Why?
| Perciformes | 1 | 2001 | 17 | 0.010 |
Why?
| Muscle Spindles | 1 | 1981 | 6 | 0.010 |
Why?
| Clomiphene | 1 | 1981 | 15 | 0.010 |
Why?
| Amenorrhea | 1 | 1981 | 27 | 0.010 |
Why?
| Skin | 1 | 1985 | 662 | 0.010 |
Why?
| Protein Subunits | 1 | 2002 | 204 | 0.010 |
Why?
| Ovulation Induction | 1 | 1981 | 49 | 0.010 |
Why?
| Phalloidine | 1 | 2000 | 2 | 0.010 |
Why?
| Cytochalasin B | 1 | 2000 | 17 | 0.010 |
Why?
| Fibroblasts | 1 | 1985 | 839 | 0.010 |
Why?
| Biomarkers | 1 | 2011 | 3471 | 0.010 |
Why?
| T-Box Domain Proteins | 1 | 2001 | 93 | 0.010 |
Why?
| Stimulation, Chemical | 1 | 2000 | 57 | 0.010 |
Why?
| Kruppel-Like Factor 6 | 1 | 2000 | 1 | 0.010 |
Why?
| Tubocurarine | 1 | 2000 | 4 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 2003 | 804 | 0.010 |
Why?
| Ondansetron | 1 | 2000 | 8 | 0.010 |
Why?
| Spinal Cord | 1 | 2003 | 351 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2008 | 1919 | 0.010 |
Why?
| Ferrets | 1 | 2000 | 20 | 0.010 |
Why?
| Serotonin Antagonists | 1 | 2000 | 30 | 0.010 |
Why?
| Fatty Acids | 1 | 2003 | 386 | 0.010 |
Why?
| Exocytosis | 1 | 2000 | 89 | 0.010 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2000 | 61 | 0.010 |
Why?
| Cerebellar Nuclei | 1 | 1980 | 11 | 0.010 |
Why?
| Actin Cytoskeleton | 1 | 2000 | 93 | 0.010 |
Why?
| Microscopy, Confocal | 1 | 2000 | 299 | 0.010 |
Why?
| Ritodrine | 1 | 1999 | 1 | 0.010 |
Why?
| Son of Sevenless Proteins | 1 | 1999 | 4 | 0.010 |
Why?
| Virulence Factors, Bordetella | 1 | 1999 | 19 | 0.010 |
Why?
| Pertussis Toxin | 1 | 1999 | 26 | 0.010 |
Why?
| Imidazoles | 1 | 2000 | 217 | 0.010 |
Why?
| Prospective Studies | 1 | 2010 | 6276 | 0.010 |
Why?
| Endothelin Receptor Antagonists | 1 | 1999 | 58 | 0.010 |
Why?
| Receptor, Endothelin A | 1 | 1999 | 59 | 0.010 |
Why?
| Ion Transport | 1 | 1999 | 55 | 0.010 |
Why?
| Cations | 1 | 1999 | 79 | 0.010 |
Why?
| Zebrafish Proteins | 1 | 2001 | 246 | 0.010 |
Why?
| Permeability | 1 | 1999 | 150 | 0.010 |
Why?
| Postural Balance | 1 | 1981 | 182 | 0.010 |
Why?
| Oocytes | 1 | 1999 | 171 | 0.010 |
Why?
| Hemolytic Plaque Technique | 1 | 1997 | 30 | 0.010 |
Why?
| Secretory Rate | 1 | 1997 | 16 | 0.010 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 43 | 0.010 |
Why?
| Indoles | 1 | 2000 | 309 | 0.010 |
Why?
| MAP Kinase Kinase 2 | 1 | 1997 | 27 | 0.010 |
Why?
| Cervix Uteri | 1 | 1998 | 44 | 0.010 |
Why?
| Gadolinium DTPA | 1 | 1998 | 54 | 0.010 |
Why?
| Colorado | 1 | 2007 | 4116 | 0.010 |
Why?
| Endometrium | 1 | 1998 | 59 | 0.010 |
Why?
| Leukemia Inhibitory Factor | 1 | 1997 | 6 | 0.010 |
Why?
| Myometrium | 1 | 1998 | 35 | 0.010 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 1998 | 139 | 0.010 |
Why?
| MAP Kinase Kinase 1 | 1 | 1997 | 66 | 0.010 |
Why?
| Pentagastrin | 1 | 1997 | 1 | 0.010 |
Why?
| Devazepide | 1 | 1997 | 1 | 0.010 |
Why?
| Famotidine | 1 | 1997 | 2 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2000 | 732 | 0.010 |
Why?
| Benzodiazepinones | 1 | 1997 | 14 | 0.010 |
Why?
| Atropine | 1 | 1997 | 31 | 0.010 |
Why?
| Methacholine Chloride | 1 | 1997 | 47 | 0.010 |
Why?
| Pituitary Gland, Posterior | 1 | 1997 | 2 | 0.010 |
Why?
| Genes, ras | 1 | 1997 | 91 | 0.010 |
Why?
| Janus Kinase 2 | 1 | 1997 | 31 | 0.010 |
Why?
| Colchicine | 1 | 1997 | 24 | 0.010 |
Why?
| STAT1 Transcription Factor | 1 | 1997 | 64 | 0.010 |
Why?
| Histamine | 1 | 1997 | 65 | 0.010 |
Why?
| Injections, Intraventricular | 1 | 1997 | 72 | 0.010 |
Why?
| Muscarinic Antagonists | 1 | 1997 | 27 | 0.010 |
Why?
| Luciferases | 1 | 1997 | 140 | 0.010 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 148 | 0.010 |
Why?
| Formaldehyde | 1 | 1997 | 47 | 0.010 |
Why?
| Clusterin | 1 | 1996 | 10 | 0.010 |
Why?
| Chemokine CXCL1 | 1 | 1997 | 66 | 0.010 |
Why?
| Histamine H2 Antagonists | 1 | 1997 | 29 | 0.010 |
Why?
| Tyrosine | 1 | 1997 | 219 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2006 | 2393 | 0.010 |
Why?
| Seizures | 1 | 1980 | 344 | 0.010 |
Why?
| Stomach | 1 | 1997 | 101 | 0.010 |
Why?
| Neoplasm Invasiveness | 1 | 1998 | 445 | 0.010 |
Why?
| Gene Deletion | 1 | 1998 | 355 | 0.010 |
Why?
| Stereoisomerism | 1 | 1996 | 91 | 0.010 |
Why?
| ROC Curve | 1 | 1998 | 451 | 0.010 |
Why?
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1996 | 4 | 0.010 |
Why?
| Leptin | 1 | 1997 | 211 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 1999 | 616 | 0.010 |
Why?
| Dogs | 1 | 1997 | 341 | 0.010 |
Why?
| Muscle, Smooth | 1 | 1996 | 150 | 0.010 |
Why?
| Chorionic Gonadotropin | 1 | 1976 | 78 | 0.010 |
Why?
| STAT3 Transcription Factor | 1 | 1997 | 174 | 0.010 |
Why?
| Microscopy, Electron | 1 | 1996 | 409 | 0.010 |
Why?
| Electric Stimulation | 2 | 1973 | 263 | 0.010 |
Why?
| Conjugation, Genetic | 1 | 1975 | 5 | 0.010 |
Why?
| Mannose | 1 | 1975 | 21 | 0.010 |
Why?
| Chlorides | 1 | 1996 | 130 | 0.010 |
Why?
| Glucosamine | 1 | 1975 | 12 | 0.010 |
Why?
| Receptors, FSH | 2 | 1985 | 9 | 0.010 |
Why?
| Ciliophora | 1 | 1975 | 14 | 0.010 |
Why?
| Dendrites | 1 | 1996 | 85 | 0.010 |
Why?
| Polycystic Ovary Syndrome | 1 | 1977 | 141 | 0.010 |
Why?
| Contrast Media | 1 | 1998 | 369 | 0.010 |
Why?
| gamma-Aminobutyric Acid | 1 | 1996 | 151 | 0.010 |
Why?
| Activins | 1 | 1994 | 26 | 0.010 |
Why?
| Growth Hormone-Releasing Hormone | 1 | 1994 | 27 | 0.010 |
Why?
| Dexamethasone | 1 | 1996 | 316 | 0.010 |
Why?
| Cross-Cultural Comparison | 1 | 1995 | 77 | 0.010 |
Why?
| Eating | 1 | 1997 | 346 | 0.010 |
Why?
| Axons | 1 | 1996 | 179 | 0.010 |
Why?
| Adenosine | 1 | 1996 | 203 | 0.010 |
Why?
| Semantics | 1 | 1995 | 87 | 0.010 |
Why?
| HTLV-I Antibodies | 1 | 1994 | 5 | 0.010 |
Why?
| Corticotropin-Releasing Hormone | 1 | 1994 | 78 | 0.010 |
Why?
| Natural Language Processing | 1 | 1995 | 71 | 0.010 |
Why?
| Estrogens | 1 | 1996 | 315 | 0.010 |
Why?
| Cytosol | 1 | 1994 | 209 | 0.010 |
Why?
| Human T-lymphotropic virus 1 | 1 | 1994 | 23 | 0.010 |
Why?
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 1993 | 7 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1996 | 1168 | 0.010 |
Why?
| Vasoactive Intestinal Peptide | 1 | 1993 | 25 | 0.010 |
Why?
| Promoter Regions, Genetic | 1 | 1998 | 1122 | 0.010 |
Why?
| Muscles | 2 | 1988 | 326 | 0.010 |
Why?
| Seroepidemiologic Studies | 1 | 1994 | 140 | 0.010 |
Why?
| Organ Specificity | 1 | 1994 | 273 | 0.010 |
Why?
| Benztropine | 1 | 1993 | 2 | 0.010 |
Why?
| Visual Cortex | 1 | 1973 | 41 | 0.010 |
Why?
| Infusions, Parenteral | 1 | 1993 | 38 | 0.010 |
Why?
| Dopamine Antagonists | 1 | 1993 | 22 | 0.010 |
Why?
| Gonadotropins, Equine | 1 | 1992 | 3 | 0.010 |
Why?
| Aldehyde-Lyases | 1 | 1992 | 2 | 0.010 |
Why?
| Hypophysectomy | 1 | 1992 | 15 | 0.010 |
Why?
| Steroid 17-alpha-Hydroxylase | 1 | 1992 | 4 | 0.010 |
Why?
| 3-Hydroxysteroid Dehydrogenases | 1 | 1992 | 9 | 0.010 |
Why?
| 17-Hydroxysteroid Dehydrogenases | 1 | 1992 | 4 | 0.010 |
Why?
| Electromyography | 2 | 1988 | 324 | 0.010 |
Why?
| Membrane Proteins | 1 | 1999 | 1024 | 0.010 |
Why?
| Aromatase | 1 | 1992 | 31 | 0.010 |
Why?
| Synapses | 1 | 1996 | 336 | 0.010 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 1992 | 108 | 0.010 |
Why?
| Oligodendroglia | 1 | 1994 | 149 | 0.010 |
Why?
| Cortical Spreading Depression | 1 | 1971 | 13 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 1997 | 2262 | 0.010 |
Why?
| Amino Acids | 1 | 1975 | 454 | 0.010 |
Why?
| Androgens | 1 | 1992 | 165 | 0.010 |
Why?
| Epithelial Cells | 1 | 1996 | 961 | 0.010 |
Why?
| Neuroglia | 1 | 1971 | 150 | 0.010 |
Why?
| Monitoring, Immunologic | 1 | 1989 | 23 | 0.010 |
Why?
| Carcinoembryonic Antigen | 1 | 1989 | 37 | 0.010 |
Why?
| Visual Pathways | 2 | 1984 | 44 | 0.010 |
Why?
| Dermoid Cyst | 1 | 1989 | 12 | 0.010 |
Why?
| Mutation | 1 | 1999 | 3364 | 0.000 |
Why?
| Testosterone | 2 | 1984 | 337 | 0.000 |
Why?
| Incidence | 1 | 1994 | 2335 | 0.000 |
Why?
| RNA | 1 | 1993 | 820 | 0.000 |
Why?
| Methoxyflurane | 1 | 1966 | 2 | 0.000 |
Why?
| Acid-Base Equilibrium | 1 | 1966 | 29 | 0.000 |
Why?
| Gonadal Dysgenesis | 1 | 1985 | 8 | 0.000 |
Why?
| Obesity | 1 | 1997 | 2518 | 0.000 |
Why?
| Turner Syndrome | 1 | 1985 | 45 | 0.000 |
Why?
| Hypothermia, Induced | 1 | 1966 | 69 | 0.000 |
Why?
| Ischemia | 1 | 1988 | 363 | 0.000 |
Why?
| Spermatogenesis | 1 | 1984 | 52 | 0.000 |
Why?
| Evoked Potentials, Visual | 1 | 1984 | 31 | 0.000 |
Why?
| Superior Colliculi | 1 | 1984 | 33 | 0.000 |
Why?
| Half-Life | 1 | 1983 | 145 | 0.000 |
Why?
| Injections, Intravenous | 1 | 1983 | 204 | 0.000 |
Why?
| Aged, 80 and over | 1 | 1994 | 6423 | 0.000 |
Why?
| Reflex, Stretch | 1 | 1981 | 9 | 0.000 |
Why?
| Mechanoreceptors | 1 | 1981 | 12 | 0.000 |
Why?
| Achilles Tendon | 1 | 1981 | 39 | 0.000 |
Why?
| Brain Mapping | 1 | 1984 | 522 | 0.000 |
Why?
| Penicillin G | 1 | 1980 | 7 | 0.000 |
Why?
| Nerve Block | 1 | 1981 | 62 | 0.000 |
Why?
| Cerebellar Cortex | 1 | 1980 | 21 | 0.000 |
Why?
| Purkinje Cells | 1 | 1980 | 66 | 0.000 |
Why?
| Leg | 1 | 1981 | 227 | 0.000 |
Why?
| Drug Therapy, Combination | 1 | 1981 | 962 | 0.000 |
Why?
| Antibiotics, Antitubercular | 1 | 1956 | 35 | 0.000 |
Why?
| Neoplasms, Experimental | 1 | 1956 | 153 | 0.000 |
Why?
| Geniculate Bodies | 1 | 1973 | 12 | 0.000 |
Why?
| Potassium | 1 | 1971 | 128 | 0.000 |
Why?
| Anti-Bacterial Agents | 1 | 1956 | 1485 | 0.000 |
Why?
| Chromatography, Gas | 1 | 1966 | 27 | 0.000 |
Why?
| Antineoplastic Agents | 1 | 1956 | 1893 | 0.000 |
Why?
| Plethysmography | 1 | 1966 | 103 | 0.000 |
Why?
| Brain Diseases | 1 | 1966 | 127 | 0.000 |
Why?
| Cardiovascular Diseases | 1 | 1966 | 1729 | 0.000 |
Why?
|
|
Miyake's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|